Illumina and Pillar Biosciences partner to improve access to personalized cancer treatment options

Illumina, Inc. (NASDAQ: ILMN) and Pillar Biosciences Inc. have joined forces in a strategic partnership to expand the availability of Pillar's suite of oncology assays worldwide as part of Illumina's oncology product portfolio. The goal of this collaboration is to improve the efficiency, accuracy, and cost-effectiveness of oncology testing by utilizing advanced sequencing techniques, ultimately ..